Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 98 results for "astrazeneca"

AstraZeneca Pharma gains 3% on plan to launch lung cancer drug in India
Money Control

AstraZeneca Pharma gains 3% on plan to launch lung cancer drug...

Osimertinib is an oral anti-cancer drug for management of lung cancer. Money Control, 1 day ago

118 images for astrazeneca

Money Control, 1 day ago
Money Control, 1 month ago
Money Control, 1 month ago
Reuters, 2 months ago
Reuters, 2 months ago
Money Control, 2 months ago
Reuters, 2 months ago
Reuters, 2 months ago
Reuters, 2 months ago
Reuters, 2 months ago

AstraZeneca says CEO Pascal Soriot will host earnings call

By Kate Holton and Paul Sandle LONDON (Reuters) - Anglo-Swedish pharmaceutical firm AstraZeneca said on Friday its chief executive, Pascal Soriot, would host a results call with reporters on July 27, after refusing to comment on speculation this week that he ...
 Sify1 week ago AstraZeneca's silence on CEO helps wipe out 3 billion pounds  Business Standard1 week ago

AstraZeneca moves up after reports of getting marketing nod for drug

AstraZeneca Pharma India gained 1.53% to Rs 929.50 at 14:45 IST on BSE after the report suggested that company received marketing authorisation from the Drug Controller General of India for Symbicort.
 Business Standard1 month ago AstraZeneca gets marketing nod for asthma drug Symbicort  DNA1 month ago Astrazeneca Pharma India gains after DCGI nod for asthma drug  Business Standard1 month ago AstraZeneca Pharma gets Indian drug regulators' nod for Symbicort Turbuhaler  Myiris1 month ago
Money Control

AstraZeneca sells antacid brand Neksium to Pfizer India for Rs 75 cr

Deal to help Pfizer, which also owns Gelusil brand, strengthen its presence in gastrointestinal area BS B2B Bureau | Mumbai June 1, 2017 Last Updated at 13:12 IST AstraZeneca AB, Sweden, has sold its antacid brand Neksium to Pfizer Ltd, which also owns ...
 Business Standard1 month ago Pfizer shares soar over 7 pc on AstraZeneca deal  Business Standard1 month ago Pfizer enters into agreement with AstraZeneca to acquire Neksium brand  Myiris1 month ago Pfizer to acquire Neksium brand from AstraZeneca for Rs 75 cr  DNA1 month ago
Money Control

Bitter pill for AstraZeneca Pharma after reverse turnaround in Q4

AstraZeneca Pharma India lost 3.2% to Rs 960 at 13:21 IST on BSE after the company reported net loss of Rs 2.88 crore in Q4 March 2017, compared with net profit of Rs 0.56 crore in Q4 March 2016.
 Business Standard2 months ago Astrazeneca Pharma India reports standalone net loss of Rs 2.88 crore in the March 2017 quarter  Business Standard2 months ago AstraZeneca Pharma, Nitta Gelatin down 4-9% on poor Q4 numbers  Money Control2 months ago AstraZeneca Pharma India Q4 net loss at Rs 2.87 cr  DNA2 months ago

Pfizer buys AstraZeneca's Neksium antacid

Gelusil and Mucaine are two other drugs in the antacid space the company has
 Business Standard1 month ago Pfizer buys AstraZeneca's drug for Rs 75 cr  Prokerala1 month ago Pfizer to buy AstraZeneca's antacid Neksium for Rs 75 cr  Business Standard1 month ago
Money Control

Alembic gets USFDA nod for generic hypertension drug

The company#39;s product is therapeutically equivalent to AstraZeneca Pharmaceuticals#39; Atacand tablets which are indicated for treatment of hypertension, Alembic today said in a regulatory filing.
 Money Control1 month ago

DCGI grants approval for AstraZeneca's inhaler to treat asthma

Symbicort Turbuhaler contains two active ingredients in one inhaler - budesonide and formoterol
 Business Standard1 month ago
Money Control

Stocks in the news: RIL, Lupin, Tata Motors, Astrazeneca, Century Ply, IOC, Ipca

Reliance Industries | Lupin | Tata Motors | Adhunik Metals | Wipro | Astrazeneca Pharma | Century Plyboards | Havells India | DB Corp | GE Shipping | Pennar Industries | IOC and Ipca Labs are stocks, which are in the news today.
 Money Control1 month ago

AstraZeneca holds Britain's FTSE back, Carillion loses last 'buy' rating

British shares underperformed in Europe on Thursday, with AstraZeneca weighing on the healthcare sector and BP and Royal Dutch Shell tracking crude prices lower.
 DNA1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less